[governance] Global Pharma Calls On ICANN To Act Against Online Counterfeits
Riaz K Tayob
riaz.tayob at gmail.com
Thu Aug 2 04:42:15 EDT 2012
[After Global Pharma got WHO to do some work on this, then poor
countries realised that that this was an industry driven process, they
protested at WHO, and WHO only relented after getting a number of
thwacks... I guess ICANN will more amenable given its lack of legitimacy
and "can do" spirit...after all it was ICANN et al that contributed to
make domain names equivalent to trademarks... for that there is no
problem going to WIPO... an UN body... perhaps cos there is money
there... not to be crass of course... ]
Global Pharma Calls On ICANN To Act Against Online Counterfeits
Published on 28 July 2012 @ 2:06 pm
Print This Post
<http://www.ip-watch.org/2012/07/28/global-pharma-calls-on-icann-to-act-against-online-counterfeits/print/>
Print This Post
<http://www.ip-watch.org/2012/07/28/global-pharma-calls-on-icann-to-act-against-online-counterfeits/print/>
Intellectual Property Watch
The international pharmaceutical industry this week released a policy
statement targeting counterfeit medicines on the internet. Among the
recommendations was for the Internet Corporation for Assigned Names and
Numbers (ICANN) to join the fight.
At the same time, the Center for Safe Internet Pharmacies was launched
in the United States, aimed at taking down illegal internet pharmacies.
More information about the CSIP is available here
<http://www.safemedsonline.org/>.
Four research-based industry associations joined together to issue a
joint policy statement
<http://www.efpia.eu/position-papers/internet-sales-and-access-safe-medicines>
on counterfeits online.
The groups are the International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA), Pharmaceutical Research and
Manufacturers of America (PhRMA), European Federation of Pharmaceutical
Industries and Associations (EFPIA), and Japanese Pharmaceutical
Manufacturers Association (JPMA).
The groups showed support for governments, law enforcement, the private
sector and any others, working to stop counterfeit medicines.
And they said, "We call upon [ICANN], which oversees the assignment of
generic top level domains and accredits domain registrars, to take
appropriate actions and ensure accountability measures in order to
protect Internet users from illegitimate online sites that are engaged
in the illicit sale of prescription medicines."
Up till now, ICANN has been explicitly considered to be a technical
oversight body with no policy authority.
But the stakes are high, industry says. "Everybody is at risk of
counterfeiting," said Eduardo Pisani, IFPMA director general.
"Counterfeiting is a crime against patients and poses a public health
risk that can lead to treatment resistance, extended illness, disability
and even death."
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.igcaucus.org/pipermail/governance/attachments/20120802/226c3b64/attachment.htm>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: printer_famfamfam.gif
Type: image/gif
Size: 1035 bytes
Desc: not available
URL: <http://lists.igcaucus.org/pipermail/governance/attachments/20120802/226c3b64/attachment.gif>
-------------- next part --------------
____________________________________________________________
You received this message as a subscriber on the list:
governance at lists.igcaucus.org
To be removed from the list, visit:
http://www.igcaucus.org/unsubscribing
For all other list information and functions, see:
http://lists.igcaucus.org/info/governance
To edit your profile and to find the IGC's charter, see:
http://www.igcaucus.org/
Translate this email: http://translate.google.com/translate_t
More information about the Governance
mailing list